NASDAQ:MITO
Stealth BioTherapeutics
- Stock
locale
Cayman Islands
market
STOCKSindustry
Biotechnologywebsite
www.stealthbt.comipo date
Feb 15, 2019
Stealth BioTherapeutics Corp, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. Its lead product candidate is Elamipretide that is in phase 3 clinical trial to treat barth syndrome, phase 2/3 clinical trial for the treatment of duchenne cardiomyopathy, phase 2a clin...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus